Home / Advanced Search

  • Title/Keywords

  • Author/Affliations

  • Journal

  • Article Type

  • Start Year

  • End Year

Update SearchingClear
  • Articles
  • Online
Search Results (2)
  • Open Access

    ARTICLE

    Optimization and Characterization of Combined Degumming Process of Typha angustata L. Stem Fibers

    Sana Rezig*, Foued Khoffi, Mounir Jaouadi, Asma Eloudiani, Slah Msahli

    Journal of Renewable Materials, Vol.12, No.6, pp. 1071-1086, 2024, DOI:10.32604/jrm.2024.049935 - 02 August 2024

    Abstract Plant derived natural fibers have been widely investigated as alternatives to synthetic fibers in reinforcing polymers. Researchers over the years have explored many plant fibers using different extraction processes to study their physical, chemical, and mechanical properties. In this context, the present study relates to the extraction, characterization, and optimization of Typha angustata L. stem fibers. For this purpose, desirability functions and response surface methodology were applied to simultaneously optimize the diameter (D), linear density (LD); yield (Y), lignin fraction (L), and tenacity (T) of Typha stem fibers. Typha stems have been subjected to both alkali (NaOH) and enzymatic… More > Graphic Abstract

    Optimization and Characterization of Combined Degumming Process of <i>Typha angustata</i> L. Stem Fibers

  • Open Access

    ARTICLE

    Three Combined Treatments, a Novel HDAC Inhibitor OBP-801/YM753, 5-Fluorouracil, and Paclitaxel, Induce G2 Phase Arrest Through the p38 Pathway in Human Ovarian Cancer Cells

    Makoto Akiyama*†, Yoshihiro Sowa*, Tomoyuki Taniguchi*, Motoki Watanabe*, Shingo Yogosawa, Jo Kitawaki,Toshiyuki Sakai*

    Oncology Research, Vol.25, No.8, pp. 1245-1252, 2017, DOI:10.3727/096504017X14850164661097

    Abstract Ovarian cancer is the most lethal disease among gynecological malignancies. More effective therapy is required to counter high recurrence rates and chemotherapy resistance. We investigated the efficacy and molecular mechanisms of three combined treatments (TCTs)—a novel histone deacetylase (HDAC) inhibitor OBP-801/YM753, 5-fluorouracil (5-FU), and paclitaxel (PTX)—in human ovarian cancer SKOV-3 and OVCAR-3 cells. The inhibition of cell growth was stronger with TCTs than with each single agent and with two combined treatments. The TCTs significantly induce G2 phase arrest in both cell lines. We then analyzed the molecular mechanisms and found that the TCTs increased the More >

Displaying 1-10 on page 1 of 2. Per Page